Since their launch in 2012, there have been over 25 million Seresto Collars bought. In truth, knowledge launched by the Bayer Pharmaceutical Company in 2019 confirmed that over $300 million in income had been collected from the acquisition of Seresto collars alone.

The collars work to stop flea and tick infestations in family pets by releasing two lively substances that unfold throughout your canine’s pores and skin and coat over time. The draw of this product, for a lot of pet mother and father, is the inexpensive price and the truth that Seresto claims to supply a full eight months of safety as long as the collar is correctly fitted and maintained.


As nice as this product could appear, there have been many stories surfacing of sickness, damage, and even demise occurring to beloved companions that sport the Seresto collar. And many mother and father are involved that there could also be a hyperlink between the collar and the well being points arising in canine and cats with no historical past of bodily sickness.

Common points referred to in shopper complaints embody redness and irritation of the pores and skin beneath the collar, hair loss, and even gastrointestinal abnormalities similar to vomiting, diarrhea, or sudden lack of urge for food.

What Are Veterinarians Saying?

In March of 2021, the Veterinary Information Network interviewed two licensed veterinary toxicologists in an effort to find whether or not or not the hyperlink between Seresto collars and the reported well being points may be scientifically confirmed. The consensus was that these toxicologists would have a tough time making sense of the connection between the signs reported and the collars themselves because of the nature of the signs.

“Looking at these reports, these are very random things, ranging from ruptured ear drums… to liver failure, to heart problems, to kidney failure. The fact that the signs are very random makes me think that probably (the collar) is not involved.” – Dr. Tina Wismer, medical director of the ASPCA Animal Poison Control Center


What Does Elanco Have To Say?

On March 18, 2021, a consultant for Elanco Animal Health, the pharmaceutical firm that at present owns the patent for Seresto collars, launched a press assertion defending the integrity of the collars. This got here after a listening to on the U.S. Court of Representatives was held requesting the non permanent elimination of Seresto collars from the market whereas an investigation was carried out. In response to this request, Elanco acknowledged the next:

 “All data and scientific evaluation used during the product registration process, and through Elanco’s robust pharmacovigilance review, supports the product safety profile and efficacy. Therefore, no market action, such as recall, is warranted, nor has it been suggested from any regulatory agency.”

While there have been rumors circulating of the opportunity of counterfeit collars coming from big-name manufacturing giants similar to Amazon, these rumors haven’t been confirmed by any analysis or scientific knowledge.

Regardless of those rumors, veterinarians proceed to encourage pet mother and father to buy their flea, tick, and heartworm prevention from verifiable producers and distributors for the continued well being and security of all pets.

H/T to Gizmodo
Featured Image by way of Facebook

(adsbygoogle = window.adsbygoogle || []).push({});


Please enter your comment!
Please enter your name here